"Kidney disease belongs to patients with chronic diseases, and currently in the Chinese market, payment is heavily reliant on national medical insurance. The core demand of the medical insurance bureau is to maintain the long-term renal function of patients, and the relevant trial data will become an important factor in determining the medical insurance payment price of products in the future."

draft a statement in english 肾病属于慢病患者当前中国市场支付依赖国家医保;医保局的核心诉求在于长期保存患者的肾功能相关试验数据将成为未来决定产品医保支付价的重要因素

原文地址: https://www.cveoy.top/t/topic/5Si 著作权归作者所有。请勿转载和采集!

免费AI点我,无需注册和登录